SEARCH

SEARCH BY CITATION

References

  • Bear, M.F., Huber, K.M. & Warren, S.T. (2004) The mGluR theory of fragile X mental retardation. Trends Neurosci 27, 370377.
  • Boulanger, L.M., Lombroso, P.J., Raghunathan, A., During, M.J., Wahle, P. & Naegele, J.R. (1995) Cellular and molecular characterization of a brain-enriched protein tyrosine phosphatase. J Neurosci 15, 15321544.
  • Boyce-Rustay, J.M. & Holmes, A. (2006) Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice. Neuropsychopharmacology (Berl) 31, 24052414.
  • Boyle, L. & Kaufmann, W.E. (2010) The behavioral phenotype of FMR1 mutations. Am J Med Genet C Semin Med Genet 154C, 469476.
  • Briggs, S.W., Walker, J., Asik, K., Lombroso, P., Naegele, J. & Aaron, G. (2011) STEP regulation of seizure thresholds in the hippocampus. Epilepsia 52, 497506.
  • Bult, A., Zhao, F., Dirkx, R., Jr., Sharma, E., Lukacsi, E., Solimena, M., Naegele, J.R. & Lombroso, P.J. (1996) STEP61: a member of a family of brain-enriched PTPs is localized to the endoplasmic reticulum. J Neurosci 16, 78217831.
  • Chen, X., Mariappan, S.V., Catasti, P., Ratliff, R., Moyzis, R.K., Laayoun, A., Smith, S.S., Bradbury, E.M. & Gupta, G. (1995) Hairpins are formed by the single DNA strands of the fragile X triplet repeats: structure and biological implications. Proc Natl Acad Sci USA 92, 51995203.
  • Chuang, S.C., Zhao, W., Bauchwitz, R., Yan, Q., Bianchi, R. & Wong, R.K. (2005) Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model. J Neurosci 25, 80488055.
  • Comery, T.A., Harris, J.B., Willems, P.J., Oostra, B.A., Irwin, S.A., Weiler, I.J. & Greenough, W.T. (1997) Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci USA 94, 54015404.
  • Cornish, K., Turk, J. & Hagerman, R. (2008) The fragile X continuum: new advances and perspectives. J Intellect Disabil Res 52, 469482.
  • Crawley, J. & Goodwin, F.K. (1980) Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 13, 167170.
  • Crawley, J.N. (2007) Mouse behavioral assays relevant to the symptoms of autism. Brain Pathol 17, 448459.
  • Darnell, J.C., Jensen, K.B., Jin, P., Brown, V., Warren, S.T. & Darnell, R.B. (2001) Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107, 489499.
  • Darnell, J.C., Van Driesche, S.J., Zhang, C., Hung, K.Y., Mele, A., Fraser, C.E., Stone, E.F., Chen, C., Fak, J.J., Chi, S.W., Licatalosi, D.D., Richter, J.D. & Darnell, R.B. (2011) FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247261.
  • Dolen, G., Osterweil, E., Rao, B.S., Smith, G.B., Auerbach, B.D., Chattarji, S. & Bear, M.F. (2007) Correction of fragile X syndrome in mice. Neuron 56, 955962.
  • Faingold, C.L. (1999) Neuronal networks in the genetically epilepsy-prone rat. Adv Neurol 79, 311321.
  • Faingold, C.L. & Randall, M.E. (1999) Neurons in the deep layers of superior colliculus play a critical role in the neuronal network for audiogenic seizures: mechanisms for production of wild running behavior. Brain Res 815, 250258.
  • Gibson, J.R., Bartley, A.F., Hays, S.A. & Huber, K.M. (2008) Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome. J Neurophysiol 100, 26152626.
  • Goebel-Goody, S.M., Baum, M., Paspalas, C.D., Fernandez, S.M., Carty, N.C., Kurup, P. & Lombroso, P.J. (2012) Therapeutic implications for striatal-enriched protein tyrosine phosphatase (STEP) in neuropsychiatric disorders. Pharmacol Rev 64, 6587.
  • Goebel-Goody, S.M., Davies, K.D., Alvestad Linger, R.M., Freund, R.K. & Browning, M.D. (2009) Phospho-regulation of synaptic and extrasynaptic N-methyl-D-aspartate receptors in adult hippocampal slices. Neuroscience 158, 14461459.
  • Gross, C., Nakamoto, M., Yao, X., Chan, C.B., Yim, S.Y., Ye, K., Warren, S.T. & Bassell, G.J. (2010) Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome. J Neurosci 30, 1062410638.
  • Harris, S.W., Hessl, D., Goodlin-Jones, B., Ferranti, J., Bacalman, S., Barbato, I., Tassone, F., Hagerman, P.J., Herman, H. & Hagerman, R.J. (2008) Autism profiles of males with fragile X syndrome. Am J Ment Retard 113, 427438.
  • Hays, S.A., Huber, K.M. & Gibson, J.R. (2011) Altered neocortical rhythmic activity states in Fmr1 KO mice are due to enhanced mGluR5 signaling and involve changes in excitatory circuitry. J Neurosci 31, 1422314234.
  • Herrera, D.G. & Robertson, H.A. (1996) Activation of c-fos in the brain. Prog Neurobiol 50, 83107.
  • Hollingsworth, E.B., McNeal, E.T., Burton, J.L., Williams, R.J., Daly, J.W. & Creveling, C.R. (1985) Biochemical characterization of a filtered synaptoneurosome preparation from guinea pig cerebral cortex: cyclic adenosine 3′:5′-monophosphate-generating systems, receptors, and enzymes. J Neurosci 5, 22402253.
  • Hou, L., Antion, M.D., Hu, D., Spencer, C.M., Paylor, R. & Klann, E. (2006) Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression. Neuron 51, 441454.
  • Huber, K.M., Gallagher, S.M., Warren, S.T. & Bear, M.F. (2002) Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA 99, 77467750.
  • Kaufmann, W.E. & Reiss, A.L. (1999) Molecular and cellular genetics of fragile X syndrome. Am J Med Genet 88, 1124.
  • Kim, S.H., Markham, J.A., Weiler, I.J. & Greenough, W.T. (2008) Aberrant early-phase ERK inactivation impedes neuronal function in fragile X syndrome. Proc Natl Acad Sci USA 105, 44294434.
  • Krueger, D.D. & Bear, M.F. (2011) Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu Rev Med 62, 411429.
  • Laggerbauer, B., Ostareck, D., Keidel, E.M., Ostareck-Lederer, A. & Fischer, U. (2001) Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum Mol Genet 10, 329338.
  • Le Gal La Salle, G. & Naquet, R. (1990) Audiogenic seizures evoked in DBA/2 mice induce c-fos oncogene expression into subcortical auditory nuclei. Brain Res 518, 308312.
  • Lindzey, G., Winston, H. & Manosevitz, M. (1961) Social dominance in inbred mouse strains. Nature 191, 474476.
  • Liu, Z.H., Chuang, D.M. & Smith, C.B. (2011) Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome. Int J Neuropsychopharmacol 14, 618630.
  • Liu, Z.H. & Smith, C.B. (2009) Dissociation of social and nonsocial anxiety in a mouse model of fragile X syndrome. Neurosci Lett 454, 6266.
  • Lu, R., Wang, H., Liang, Z., Ku, L., O’Donnell, W.T., Li, W., Warren, S.T. & Feng, Y. (2004) The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. Proc Natl Acad Sci USA 101, 1520115206.
  • Luscher, C. & Huber, K.M. (2010) Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease. Neuron 65, 445459.
  • McNaughton, C.H., Moon, J., Strawderman, M.S., Maclean, K.N., Evans, J. & Strupp, B.J. (2008) Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome. Behav Neurosci 122, 293300.
  • Mines, M.A., Yuskaitis, C.J., King, M.K., Beurel, E. & Jope, R.S. (2010) GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism. PLoS One 5, e9706.
  • Mineur, Y.S., Huynh, L.X. & Crusio, W.E. (2006) Social behavior deficits in the Fmr1 mutant mouse. Behav Brain Res 168, 172175.
  • Morgan, J.I., Cohen, D.R., Hempstead, J.L. & Curran, T. (1987) Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237, 192197.
  • Moy, S.S., Nadler, J.J., Young, N.B., Nonneman, R.J., Grossman, A.W., Murphy, D.L., D’Ercole, A.J., Crawley, J.N., Magnuson, T.R. & Lauder, J.M. (2009) Social approach in genetically engineered mouse lines relevant to autism. Genes Brain Behav 8, 129142.
  • Muddashetty, R.S., Kelic, S., Gross, C., Xu, M. & Bassell, G.J. (2007) Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome. J Neurosci 27, 53385348.
  • Munoz, J.J., Tarrega, C., Blanco-Aparicio, C. & Pulido, R. (2003) Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents. Biochem J 372, 193201.
  • Murcia, C.L., Gulden, F. & Herrup, K. (2005) A question of balance: a proposal for new mouse models of autism. Int J Dev Neurosci 23, 265275.
  • Musumeci, S.A., Bosco, P., Calabrese, G., Bakker, C., De Sarro, G.B., Elia, M., Ferri, R. & Oostra, B.A. (2000) Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia 41, 1923.
  • N’Gouemo, P. & Faingold, C.L. (1999) The periaqueductal grey is a critical site in the neuronal network for audiogenic seizures: modulation by GABA(A), NMDA and opioid receptors. Epilepsy Res 35, 3946.
  • Nguyen, T.H., Liu, J. & Lombroso, P.J. (2002) Striatal enriched phosphatase 61 dephosphorylates Fyn at phosphotyrosine 420. J Biol Chem 277, 2427424279.
  • Njung'e, K. & Handley, S.L. (1991) Evaluation of marble-burying behavior as a model of anxiety. Pharmacol Biochem Behav 38, 6367.
  • Olmos-Serrano, J.L., Paluszkiewicz, S.M., Martin, B.S., Kaufmann, W.E., Corbin, J.G. & Huntsman, M.M. (2010) Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome. J Neurosci 30, 99299938.
  • Osterweil, E.K., Krueger, D.D., Reinhold, K. & Bear, M.F. (2010) Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome. J Neurosci 30, 1561615627.
  • Oyama, T., Goto, S., Nishi, T., Sato, K., Yamada, K., Yoshikawa, M. & Ushio, Y. (1995) Immunocytochemical localization of the striatal enriched protein tyrosine phosphatase in the rat striatum: a light and electron microscopic study with a complementary DNA-generated polyclonal antibody. Neuroscience 69, 869880.
  • Paluszkiewicz, S.M., Olmos-Serrano, J.L., Corbin, J.G. & Huntsman, M.M. (2011) Impaired inhibitory control of cortical synchronization in fragile x syndrome. J Neurophysiol 106, 22642272.
  • Park, S., Park, J.M., Kim, S., Kim, J.A., Shepherd, J.D., Smith-Hicks, C.L., Chowdhury, S., Kaufmann, W., Kuhl, D., Ryazanov, A.G., Huganir, R.L., Linden, D.J. & Worley, P.F. (2008) Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD. Neuron 59, 7083.
  • Paul, S., Nairn, A.C., Wang, P. & Lombroso, P.J. (2003) NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling. Nat Neurosci 6, 3442.
  • Peier, A.M., McIlwain, K.L., Kenneson, A., Warren, S.T., Paylor, R. & Nelson, D.L. (2000) (Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features. Hum Mol Genet 9, 11451159.
  • Pelkey, K.A., Askalan, R., Paul, S., Kalia, L.V., Nguyen, T.H., Pitcher, G.M., Salter, M.W. & Lombroso, P.J. (2002) Tyrosine phosphatase STEP is a tonic brake on induction of long-term potentiation. Neuron 34, 127138.
  • Pietropaolo, S., Guilleminot, A., Martin, B., D’Amato, F.R. & Crusio, W.E. (2011) Genetic-background modulation of core and variable autistic-like symptoms in Fmr1 knock-out mice. PLoS One 6, e17073.
  • Qin, M., Kang, J. & Smith, C.B. (2002) Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA 99, 1575815763.
  • Qin, M. & Smith, C.B. (2008) Unaltered hormonal response to stress in a mouse model of fragile X syndrome. Psychoneuroendocrinology 33, 883889.
  • Rodgers, R.J. & Johnson, N.J. (1995) Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 52, 297303.
  • Ross, K.C. & Coleman, J.R. (2000) Developmental and genetic audiogenic seizure models: behavior and biological substrates. Neurosci Biobehav Rev 24, 639653.
  • Satoh, Y., Endo, S., Nakata, T., Kobayashi, Y., Yamada, K., Ikeda, T., Takeuchi, A., Hiramoto, T., Watanabe, Y. & Kazama, T. (2011) ERK2 contributes to the control of social behaviors in mice. J Neurosci 31, 1195311967.
  • Siomi, H., Siomi, M.C., Nussbaum, R.L. & Dreyfuss, G. (1993) The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell 74, 291298.
  • Snyder, E.M., Nong, Y., Almeida, C.G., Paul, S., Moran, T., Choi, E.Y., Nairn, A.C., Salter, M.W., Lombroso, P.J., Gouras, G.K. & Greengard, P. (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8, 10511058.
  • Spencer, C.M., Alekseyenko, O., Hamilton, S.M., Thomas, A.M., Serysheva, E., Yuva-Paylor, L.A. & Paylor, R. (2011) Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses. Autism Res 4, 4056.
  • Spencer, C.M., Alekseyenko, O., Serysheva, E., Yuva-Paylor, L.A. & Paylor, R. (2005) Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome. Genes Brain Behav 4, 420430.
  • Thomas, A., Burant, A., Bui, N., Graham, D., Yuva-Paylor, L.A. & Paylor, R. (2009) Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology 204, 361373.
  • Thomas, A.M., Bui, N., Graham, D., Perkins, J.R., Yuva-Paylor, L.A. & Paylor, R. (2011) Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome. Behav Brain Res 223, 310321.
  • Todd, P.K., Mack, K.J. & Malter, J.S. (2003) The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95. Proc Natl Acad Sci USA 100, 1437414378.
  • Venkitaramani, D.V., Moura, P.J., Picciotto, M.R. & Lombroso, P.J. (2011) Striatal-enriched protein tyrosine phosphatase (STEP) knockout mice have enhanced hippocampal memory. Eur J Neurosci 33, 22882298.
  • Venkitaramani, D.V., Paul, S., Zhang, Y., Kurup, P., Ding, L., Tressler, L., Allen, M., Sacca, R., Picciotto, M.R. & Lombroso, P.J. (2009) Knockout of striatal enriched protein tyrosine phosphatase in mice results in increased ERK1/2 phosphorylation. Synapse 63, 6981.
  • de Vrij, F.M., Levenga, J., van der Linde, H.C., Koekkoek, S.K., De Zeeuw, C.I., Nelson, D.L., Oostra, B.A. & Willemsen, R. (2008) Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice. Neurobiol Dis 31, 127132.
  • Weiler, I.J., Spangler, C.C., Klintsova, A.Y., Grossman, A.W., Kim, S.H., Bertaina-Anglade, V., Khaliq, H., de Vries, F.E., Lambers, F.A., Hatia, F., Base, C.K. & Greenough, W.T. (2004) Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses. Proc Natl Acad Sci USA 101, 1750417509.
  • Westmark, C.J. & Malter, J.S. (2007) FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biol 5, e52.
  • Wolff, P.H., Gardner, J., Paccla, J. & Lappen, J. (1989) The greeting behavior of fragile X males. Am J Ment Retard 93, 406411.
  • Yan, Q.J., Rammal, M., Tranfaglia, M. & Bauchwitz, R.P. (2005) Suppression of two major fragile X syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology 49, 10531066.
  • Yang, M., Silverman, J.L. & Crawley, J.N. (2011) Automated three-chambered social approach task for mice. Curr Protoc Neurosci, Chapter 8, Unit 8.26.
  • Yuskaitis, C.J., Mines, M.A., King, M.K., Sweatt, J.D., Miller, C.A. & Jope, R.S. (2010) Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome. Biochem Pharmacol 79, 632646.
  • Zalfa, F., Giorgi, M., Primerano, B., Moro, A., di Penta, A., Reis, S., Oostra, B. & Bagni, C. (2003) The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 112, 317327.
  • Zhang, Y., Kurup, P., Xu, J., Carty, N., Fernandez, S.M., Nygaard, H.B., Pittenger, C., Greengard, P., Strittmatter, S.M., Nairn, A.C. & Lombroso, P.J. (2010) Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model. Proc Natl Acad Sci USA 107, 1901419019.
  • Zhang, Y., Venkitaramani, D.V., Gladding, C.M., Zhang, Y., Kurup, P., Molnar, E., Collingridge, G.L. & Lombroso, P.J. (2008) The tyrosine phosphatase STEP mediates AMPA receptor endocytosis after metabotropic glutamate receptor stimulation. J Neurosci 28, 1056110566.